2024年06月20日,Web of Science正式发布2023年度 SCI 期刊影响因子(Impact Factor, IF)。 今天CVIA为大家带来2023心血管领域SCIE和ESCI影响因子独家梳理! 相比2022年心血管领域影响因子 2022 今年的影响因子有以下几个变化: 1. 影响因子普遍下降。 2. 心血管领域SCIE数量保持不变,仍然是143本。 3. 虽然总体影...
6月28日,2023年最新SCI影响因子(Impact Factor,IF)正式揭晓。自2023年起,影响因子只保留1位小数(此前为3位)。在医学领域,“神刊”CA-A CANCER JOURNAL FOR CLINICIANS的最新影响因子为254.7,虽仍占据榜首,但与去年和前年相比IF在持续下滑。国产期刊影...
汤森路透每年出版一本《期刊引用报告》(Journal Citation Reports,简称JCR)。JCR对86000多种SCI期刊的影响因子(Impact Factor)等指数加以统计。JCR将收录期刊分为176个不同学科类别在JCR的Journal Ranking中,主要参考当年IF,最终每个分区的期刊数量是均分的。
汤森路透每年出版一本《期刊引用报告》(Journal Citation Reports,简称JCR)。JCR对86000多种SCI期刊的影响因子(Impact Factor)等指数加以统计。JCR将收录期刊分为176个不同学科类别在JCR的Journal Ranking中,主要参考当年IF,最终每个分区的期刊数量是均分的。
documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) ...
The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric. Cites per documentYearValue Cites / Doc. (4 years) 2016 0.000 Cites / Doc. (4 years) 2017 2.531 Cites / Doc. (4 years) 2018 2.829 Cites / Doc. (4 years) 2019 3.943 Cites / Doc. (4 years...
June 2023 Focus Issue on Pulmonary Hypertension Edited byDr Jian’an Wang MD, PhD June 2022 View all special issues and article collections View all issues Partner journals Journal of the American College of Cardiology Supportsopen access JACC ...
Pages A1-A14, 163-280 (February 2024) Volume 9, Issue 1 Pages A1-A4, 1-162 (January 2024) 2023 — Volume 8 2022 — Volume 7 2021 — Volume 6 2020 — Volume 5 2019 — Volume 4 2018 — Volume 3 2017 — Volume 2 2016 — Volume 1...
August 2023 View all special issues and article collections View all issues Partner journals Journal of the American College of Cardiology Supportsopen access JACC A Journal of theAmerican College of Cardiology As the leader in its field,JACCpublishes original peer-reviewed clinical and experimental rep...
Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association AHA 2023 Scientific Sessions Lexicon Announces FDA Approval of INPEFA (Sotagliflozin) for Treatment of Heart Failure New Analyses of Sotagliflozin Showing Time to Clinical Be...